Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Sarana Meditama Metropolitan Tbk. (SAME) Price & Performance

UBC Medical Indonesia Tbk.Trade
Sarana Meditama Metropolitan Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Sarana Meditama Metropolitan Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Sarana Meditama Metropolitan Tbk. trades at Rp304 (market cap 5.22T, 900.6K 24h volume). The key difference: Sarana Meditama Metropolitan Tbk. is far larger — about 7.6× UBC Medical Indonesia Tbk.'s market cap, and Sarana Meditama Metropolitan Tbk. is more actively traded (900.6K versus 635.5K). Which is the better fit depends on your goals.

LABSSAME
Market Cap
691.25B5.22T
Volume
635.5K900.6K
Lot
6.36K9.01K
Turnover
110.15M273.71M
Average Price
173.33303.92
Value
110.15M273.71M
Indicative Equilibrium Price
174302
Indicative Equilibrium Volume
502

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SAME
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Sarana Meditama Metropolitan Tbk.

PT Sarana Meditama Metropolitan (the Company) was established based on Notarial Deed No. 27 of Budiarti Karnadi, S.H., dated November 13, 1984

Read more on SAME